Pfizer Korea to sue Kukje Pharm for amlodipine patent infringement

Published: 2008-01-24 07:00:00

Updated: 2008-01-24 07:00:00

Pfizer Korea will likely to file a lawsuit against Kukje Pharm's amlodipine besylate generic for infringement of its Norvasc patent. Pfizer Korea will seek a court injunction for kukje's Norvasc generic drug, according to the industry sources. Pfizer's proprietorship of amlodipine besylate ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK